Dose-painting intensity-modulated proton therapy for intermediate- and high-risk meningioma

BACKGROUND: Newly diagnosed WHO grade II-III or any WHO grade recurrent meningioma exhibit an aggressive behavior and thus are considered as high- or intermediate risk tumors. Given the unsatisfactory rates of disease control and survival after primary or adjuvant radiation therapy, optimization of...

Descripción completa

Detalles Bibliográficos
Autores principales: Madani, Indira, Lomax, Antony J, Albertini, Francesca, Trnková, Petra, Weber, Damien C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4404662/
https://www.ncbi.nlm.nih.gov/pubmed/25890217
http://dx.doi.org/10.1186/s13014-015-0384-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4404662/
https://www.ncbi.nlm.nih.gov/pubmed/25890217
http://dx.doi.org/10.1186/s13014-015-0384-x

Ejemplares similares